In November 2012, the FDA published a draft guidance, entitled “IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites and the Determination of Whether an IND/IDE is Needed,” which outlines recommendations for the...
Join the Healthcare Businesswomen’s Association (HBA) Indiana Chapter for a panel discussion on the new healthcare reform which takes effect in 2014. Industry professionals and government leaders will provide insights and the ramifications of the upcoming reform....
We are thrilled to announce our partnership with the state of Indiana to expand, and especially proud of all of the past week’s news coverage. Upon announcement of expansion, the company enjoyed several mentions in online news outlets, and Pearl was featured on the...
Join Pearl Staff at the ‘Celebration of Life Sciences in Indiana Networking Reception’ hosted by the RAPS Indiana Chapter. The focus of the event is to promote new connections among local regulatory professionals. A BioCrossroads representative will also...
One of the greatest challenges of clinical research is patient recruitment and retention according to Tufts Center for the Study of Drug Development (CSDD). To help clinical research professionals improve clinical trial management, Tufts CSDD analyzed more than 150...
